CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.3B
1-Year Est. Return 45.88%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$92.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
543
New
Increased
Reduced
Closed

Top Buys

1
+$16.2M
2
+$6.26M
3
+$4.07M
4
META icon
Meta Platforms (Facebook)
META
+$3.94M
5
RACE icon
Ferrari
RACE
+$2.98M

Top Sells

1
+$11.5M
2
+$7.75M
3
+$6.78M
4
ORCL icon
Oracle
ORCL
+$2.75M
5
RCL icon
Royal Caribbean
RCL
+$2.72M

Sector Composition

1 Technology 37.86%
2 Healthcare 22.63%
3 Communication Services 13.04%
4 Consumer Discretionary 10.29%
5 Consumer Staples 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNSA icon
301
Kiniksa Pharmaceuticals
KNSA
$3.6B
$304K 0.02%
7,359
-261
HTHT icon
302
Huazhu Hotels Group
HTHT
$16.2B
$301K 0.02%
6,398
-3,802
LEGN icon
303
Legend Biotech
LEGN
$3.61B
$298K 0.02%
13,720
-1,039
SNDX icon
304
Syndax Pharmaceuticals
SNDX
$2.13B
$298K 0.02%
14,163
-936
VCEL icon
305
Vericel Corp
VCEL
$1.7B
$297K 0.02%
8,241
-604
HROW icon
306
Harrow
HROW
$1.34B
$296K 0.02%
6,035
-451
DVAX
307
DELISTED
Dynavax Technologies
DVAX
$294K 0.02%
19,134
-1,421
GMAB icon
308
Genmab
GMAB
$17.2B
$293K 0.02%
9,525
+2,175
HLT icon
309
Hilton Worldwide
HLT
$68.4B
$293K 0.02%
1,021
GLUE icon
310
Monte Rosa Therapeutics
GLUE
$1.32B
$292K 0.02%
18,611
-12,214
PHVS icon
311
Pharvaris
PHVS
$1.68B
$290K 0.02%
10,438
+7,438
ANIP icon
312
ANI Pharmaceuticals
ANIP
$1.7B
$289K 0.02%
3,660
-142
SEPN
313
Septerna Inc
SEPN
$1.25B
$287K 0.02%
+10,296
OMER icon
314
Omeros
OMER
$830M
$284K 0.02%
16,553
-5,376
MNKD icon
315
MannKind Corp
MNKD
$804M
$284K 0.02%
50,037
-3,745
DGX icon
316
Quest Diagnostics
DGX
$22.1B
$278K 0.02%
+1,600
BCRX icon
317
BioCryst Pharmaceuticals
BCRX
$2.19B
$268K 0.02%
34,308
-2,488
ALVO icon
318
Alvotech
ALVO
$1.21B
$262K 0.02%
51,006
-3,862
TRVI icon
319
Trevi Therapeutics
TRVI
$1.51B
$262K 0.02%
20,895
-451
FTRE icon
320
Fortrea Holdings
FTRE
$837M
$260K 0.02%
15,057
-859
AGIO icon
321
Agios Pharmaceuticals
AGIO
$1.66B
$259K 0.02%
9,502
-682
VNET
322
VNET Group
VNET
$3.02B
$254K 0.02%
30,000
ZTS icon
323
Zoetis
ZTS
$50.9B
$252K 0.02%
2,000
TSHA icon
324
Taysha Gene Therapies
TSHA
$1.25B
$245K 0.02%
44,635
-3,182
INVA icon
325
Innoviva
INVA
$1.66B
$244K 0.02%
12,184
+1,137
11 12
13
14 15